This week on the Pod: The FDA issues guidance for COVID-19 vaccine development; Accuracy in COVID-19 antibody testing; How statins may improve outcomes for hospitalized COVID-19 patients; and in non-COVID-related news there’s a new drug approvals in breast cancer and Dravet syndome.
This week on the Pod: over-the-counter med recalls; a nasal spray approved for diabetic gastroparesis; reports of an uptick in penicillin-, ciprofloxacin-resistant meningococci; and in pandemic-related news, a possible inhaled version of remdesivir, and colchicine as a potential treatment.
The FDA has approved ReActiv8® (Mainstay Medical), an implantable neurostimulation system, for the treatment of intractable chronic low back
This week we cover the latest in the rapidly shifting perception of chloroquine and hydroxychloroquine; The polio vaccine as a potential protector against COVID-19; A new approval for Gardasil 9; And the American Gastroenterological Association draw up new guidelines for probiotic use as a treatment in gastrointestinal disorders.
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, one question has frequently been on people’s lips: when will a vaccine be ready? Recently the head of the National Institute of Allergy and Infectious Diseases (NIAID), Anthony Fauci, MD, claimed that there will be 100 million doses of a coronavirus vaccine available by the…
This week on the pod we cover the latest COVID-19 news, including antibody tests and their accuracy; A study aiming to examine treatments in children; The potential benefit of Acalabrutinib in severe cases; The WHO’s Technical Lead on COVID-19 having to backpedal a statement on transmission; And many states lodge record high numbers of infections.
The analysis included results from 2 tests that have received EUA: the SARS-CoV-2 ELISA test (Euroimmun) and the COVID-19 IgG/IgM Rapid Test Cassette (Healgen).
This week on the pod we look at results from a COVID-19 prevention trial of hydroxychloroquine; A vaccine arrival date prediction by Dr Fauci; A FDA notification regarding vial caps; A look into prescription patterns during COVID-19; And an antibody treatment trial begins.
The first patients have been dosed in a phase 1 trial evaluating a potential antibody therapy designed to treat coronavirus disease 2019. These patients received treatment at major medical centers in the US, including NYU Grossman School of Medicine and Cedars-Sinai in Los Angeles.